Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Alfacalcidol 250nanogram capsules
0906040B0AAAAAA
|
Alfacalcidol | Alfacalcidol | Nutrition and Blood | 104,919 |
|
Alfacalcidol 500nanogram capsules
0906040B0AAAIAI
|
Alfacalcidol | Alfacalcidol | Nutrition and Blood | 56,270 |
|
Alfacalcidol 1microgram capsules
0906040B0AAABAB
|
Alfacalcidol | Alfacalcidol | Nutrition and Blood | 38,540 |
|
One-Alpha 250nanogram capsules
0906040B0BBAAAA
|
One-Alpha | Alfacalcidol | Nutrition and Blood | 13,250 |
|
One-Alpha 0.5microgram capsules
0906040B0BBAHAI
|
One-Alpha | Alfacalcidol | Nutrition and Blood | 7,586 |
|
One-Alpha 1microgram capsules
0906040B0BBABAB
|
One-Alpha | Alfacalcidol | Nutrition and Blood | 4,301 |
|
Alfacalcidol 2micrograms/ml oral drops sugar free
0906040B0AAAJAJ
|
Alfacalcidol | Alfacalcidol | Nutrition and Blood | 3,872 |
|
AlfacalEss 0.25microgram capsules
0906040B0BCAAAA
|
AlfacalEss | Alfacalcidol | Nutrition and Blood | 893 |
|
AlfacalEss 0.5microgram capsules
0906040B0BCABAI
|
AlfacalEss | Alfacalcidol | Nutrition and Blood | 519 |
|
One-Alpha 2micrograms/ml oral drops
0906040B0BBAIAJ
|
One-Alpha | Alfacalcidol | Nutrition and Blood | 336 |
|
AlfacalEss 1microgram capsules
0906040B0BCACAB
|
AlfacalEss | Alfacalcidol | Nutrition and Blood | 223 |
|
AlfaD 0.25microgram capsules
0906040B0BEADAA
|
AlfaD | Alfacalcidol | Nutrition and Blood | 18 |
|
Alfacalcidol 1micrograms/0.5ml inj ampoules
0906040B0AAAFAF
|
Alfacalcidol | Alfacalcidol | Nutrition and Blood | 15 |
|
AlfaD 0.5microgram capsules
0906040B0BEABAI
|
AlfaD | Alfacalcidol | Nutrition and Blood | 15 |
|
AlfaD 1microgram capsules
0906040B0BEACAB
|
AlfaD | Alfacalcidol | Nutrition and Blood | 10 |
|
AlciDol 0.25microgram softgel capsules
0906040B0BDAAAA
|
AlciDol | Alfacalcidol | Nutrition and Blood | 3 |
|
AlciDol 0.5microgram softgel capsules
0906040B0BDABAI
|
AlciDol | Alfacalcidol | Nutrition and Blood | 3 |
|
Alfacalcidol 2micrograms/1ml solution for injection ampoules
0906040B0AAAGAG
|
Alfacalcidol | Alfacalcidol | Nutrition and Blood | 2 |
|
AlciDol 1microgram softgel capsules
0906040B0BDACAB
|
AlciDol | Alfacalcidol | Nutrition and Blood | 1 |
|
Alfacalcidol 1micrograms/5ml oral liquid
0906040B0AAAMAM
|
Alfacalcidol | Alfacalcidol | Nutrition and Blood | 1 |
|
Alfacalcidol 1mg/5ml oral liquid
0906040B0AAAKAK
|
Alfacalcidol | Alfacalcidol | Nutrition and Blood | No data available |
|
Alfacalcidol 625nanograms/5ml oral liquid
0906040B0AAALAL
|
Alfacalcidol | Alfacalcidol | Nutrition and Blood | No data available |
|
One-Alpha 1micrograms/0.5ml solution for injection ampoules
0906040B0BBAFAF
|
One-Alpha | Alfacalcidol | Nutrition and Blood | No data available |
|
One-Alpha 2micrograms/1ml solution for injection ampoules
0906040B0BBAGAG
|
One-Alpha | Alfacalcidol | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.